Abstract: Women with epilepsy (WWE) account for 0.3–0.7 % of all pregnancies, yet their care remains one of obstetrics’ most complex balancing acts. Clinicians must juggle maternal seizure control, teratogenic risks of anti-seizure medications (ASMs), rapidly changing drug pharmacokinetics, and heightened obstetric morbidity—all while supporting reproductive autonomy.
Dr. Nishi Lata Arya (2025);
Epilepsy in Pregnancy: An Integrative, Life-Course Management Framework for Optimising Maternal and Fetal Outcomes;
International Journal of Scientific and Research Publications (IJSRP)
15(9) (ISSN: 2250-3153),
DOI: http://dx.doi.org/10.29322/IJSRP.15.09.2025.p16527
